Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Ovarian Neoplasms

Free Subscription Articles published in Cancer Retrieve available abstracts of 53 articles: HTML format Text format

Single Articles

February 2010
1. KAMAT AA , Baldwin M, Urbauer D, Dang D, et al
   Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
2. GERSHENSON DM
   The heterogeneity of epithelial ovarian cancer: getting it right.
   Cancer. 2010.
   PubMed     Text format     Related articles   
   
   
   
3. SAROSY GA , Hussain MM, Seiden MV, Fuller AF, et al
   Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer.
   Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
4. BIGORIE V , Morice P, Duvillard P, Antoine M, et al
   Ovarian metastases from breast cancer: report of 29 cases.
   Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. COCCO E , Bellone S, El-Sahwi K, Cargnelutti M, et al
   Serum amyloid A: a novel biomarker for endometrial cancer.
   Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   August 2009
6. VON GRUENIGEN VE , Huang HQ, Gil KM, Gibbons HE, et al
   Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials.
   Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. WRIGHT JD , Shah M, Mathew L, Burke WM, et al
   Fertility preservation in young women with epithelial ovarian cancer.
   Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   July 2009
8. ALVERO AB , Montagna MK, Chen R, Kim KH, et al
   NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway.
   Cancer. 2009;115:3204-16.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. PAVLIK EJ , Saunders BA, Doran S, McHugh KW, et al
   The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy.
   Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. CASS I
    The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: silent no more.
    Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    June 2009
11. FARLEY JH , Tian C, Rose GS, Brown CL, et al
    Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an Analysis of Gynecologic Oncology Group Trials.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. SAMANTA AK , Huang HJ, Le XF, Mao W, et al
    MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
13. ADAMS SF , Levine DA, Cadungog MG, Hammond R, et al
    Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
14. KAMAT AA , Coffey D, Merritt WM, Nugent E, et al
    EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. KOTSOPOULOS J , Eliassen AH, Missmer SA, Hankinson SE, et al
    Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. CAO D , Humphrey PA, Allan RW
    SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
17. SU D , Smith SM, Preti M, Schwartz P, et al
    Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. PENSON RT
    Sugar fuels cancer.
    Cancer. 2009;115:918-21.
    PubMed     Text format     Related articles   
    
    
    February 2009
19. HALL MJ , Reid JE, Burbidge LA, Pruss D, et al
    BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. RAMONDETTA LM , Johnson AJ, Sun CC, Atkinson N, et al
    Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. MOORE KN , Frank SG, Alward EK, Landrum LM, et al
    Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population?
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. TIAN C , Markman M, Zaino R, Ozols RF, et al
    CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. DU BOIS A , Reuss A, Pujade-Lauraine E, Harter P, et al
    Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzi
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
24. ZORN KK , Tian C, McGuire WP, Hoskins WJ, et al
    The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma : a Gynecologic Oncology Group study.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. LAMKIN DM , Spitz DR, Shahzad MM, Zimmerman B, et al
    Glucose as a prognostic factor in ovarian carcinoma.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. LEITZMANN MF , Koebnick C, Danforth KN, Brinton LA, et al
    Body mass index and risk of ovarian cancer.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. PEARCE CL , Chung K, Pike MC, Wu AH, et al
    Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin.
    Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
28. BELLONE S , Anfossi S, O'Brien TJ, Cannon MJ, et al
    Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. SOUTH SA , Vance H, Farrell C, Dicioccio RA, et al
    Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
30. MARKMAN M
    Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy.
    Cancer. 2008;113:2832-3.
    PubMed     Text format     Related articles   
    
    
    
31. WETHINGTON SL , Herzog TJ, Seshan VE, Bansal N, et al
    Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
32. MONACO E 3RD , Kondziolka D, Mongia S, Niranjan A, et al
    Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery.
    Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
33. COLEMAN RL , Kohn EC
    Rationale for combination use of targeted agents in ovarian cancer: Do we have one?
    Cancer. 2008;.
    PubMed     Text format     Related articles   
    
    
    
34. MATEI D , Emerson RE, Schilder J, Menning N, et al
    Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : a Hoosier Oncology Group trial.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
35. ANDERSEN MR , Goff BA, Lowe KA, Scholler N, et al
    Combining a symptoms index with CA 125 to improve detection of ovarian cancer.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. PAL T , Permuth-Wey J, Sellers TA
    A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. MUNTZ HG , Malpass TW, McGonigle KF, Robertson MD, et al
    Phase 2 study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and primary peritoneal carcinoma.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
38. KWON JS , Sun CC, Peterson SK, White KG, et al
    Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. CIBULL ML , Karabakhtsian RG
    Editorial. Endometrioid epithelial ovarian cancer.
    Cancer. 2008;112:2108-11.
    PubMed     Text format     Related articles   
    
    
    
40. DI GIORGIO A , Naticchioni E, Biacchi D, Sibio S, et al
    Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
41. ZIVANOVIC O , Barakat RR, Sabbatini PJ, Brown CL, et al
    Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of Long-Term Follow-up.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. AZAD NS , Annunziata CM, Steinberg SM, Minasian L, et al
    Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy.
    Cancer. 2008;112:1726-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. HUANG L , Cronin KA, Johnson KA, Mariotto AB, et al
    Improved survival time: What can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
44. VON GRUENIGEN V , Daly B, Gibbons H, Hutchins J, et al
    Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. CHAN JK , Tian C, Monk BJ, Herzog T, et al
    Prognostic factors for high-risk early-stage epithelial ovarian cancer: a gynecologic oncology group study.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. STOREY DJ , Rush R, Stewart M, Rye T, et al
    Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
47. NOSKE A , Weichert W, Niesporek S, Roske A, et al
    Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. FENG W , Marquez RT, Lu Z, Liu J, et al
    Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. BARBOLINA MV , Adley BP, Shea LD, Stack MS, et al
    Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
50. TWOROGER SS , Gertig DM, Gates MA, Hecht JL, et al
    Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer.
    Cancer. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2007
51. MAHAJAN NN
    Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation.
    Cancer. 2007;110:2819.
    PubMed     Text format     Related articles   
    
    
    November 2007
52. DOWNS LS JR , Judson PL, Argenta PA, Ghebre R, et al
    A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma.
    Cancer. 2007;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. DONG HP , Kleinberg L, Silins I, Florenes VA, et al
    Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma.
    Cancer. 2007;.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: